InPHARM was founded in 1993. First, throughout the 1990s, it represented Boiron in France, then Omega-Pharm in Belgium, Arkopharma in France and then Pleuran in Slovakia. InPHARM has launched products for all these manufacturers, which have been and are still very successful. Examples include Oscillococcinum (influenza), Paranit (infestation) and Immunoglucan (immunity). In their time, these preparations brought new active substances to the Czech and Slovak markets, a new mechanism of action and, in the case of "low dose medicine", also a new therapeutic concept. InPHARM, which has always fulfilled its vision of bringing innovation. To this end, an extensive ten-year revitalization plan was launched in 2007, enriching the portfolio with interesting products such as injectable collagen (Guna-MD injection), effective for osteoarthritis and other musculoskeletal disorders, or infusion therapy with high-dose vitamin C supplemented with its oral form. with liposomal absorption, (Lipo C Askor Forte and Lipo C Askor Junior). The Lipo C Askor range represents the pinnacle of innovation, bringing to market not only a unique patented form of vitamin C with liposomal absorption, but also Uro C Kontrol test strips, which provide information on the body's saturation with vitamin C. This moment can be considered a huge benefit to medicine. and pharmacy, as each person is able to set adequate levels of vitamin C in the body and thus ensure the necessary antioxidant protective capacity of healthy cells and the proper functioning of the immune, nervous, locomotor and cardiovascular systems, ie systems whose proper daily activity is based on vitamin C life dependent. Otherwise, we would further rely on the general recommendation of the daily dose, which is nonsense in the case of vitamin C.

Where does inPHARM operate?

InPHARM currently operates in the Czech Republic and Slovakia and has representative offices in Prague and Bratislava. As indicated above, InPHARM's core business is the development and distribution of pharmaceuticals, medical devices and dietary supplements. The company's strategy is based mainly on the presentation of innovative original products, which it launches on the pharmaceutical market. InPHARM's largest foreign partners are, for example, Guna (Italy), Labolife (France) and dozens of other companies from Italy, Germany, the USA and Australia. InPHARM is not only focused on imports, but also exports its products, currently to Germany, Italy, Vietnam and the USA.